Professor Nikolai Petrovsky – Vaccines and biodefense: COVID-19, flu and beyond

Video by Kirby Institute - Kirby Institute Seminar Series – 8 June 2021
Professor Nikolai Petrovsky talks about the general landscape of biodefense vaccine development worldwide and Covax-19, the only active Australian clinical-stage COVID-19 vaccine candidate.

The Vaxine team based at Flinders in Adelaide led by Nikolai Petrovsky has for the last 20 years been developing novel vaccines and drugs against pathogens that pose major public health or biodefense threats including influenza, Ebola, HIV, malaria, tuberculosis, anthrax, ricin and COVID-19 with funding support from the US National Institutes of Health. The team has employed the latest technologies in synthetic gene design, biofermentation, computer-aided design and artificial intelligence to help accelerate vaccine development. This talk will discuss the general landscape of biodefense vaccine development worldwide, including progress of Vaxine’s Covax-19 candidate which remains the only active Australian clinical-stage COVID-19 vaccine candidate.

0:00​​ Webinar welcome
1:09 Introducing Professor Nikolai Petrovsky
2:03 Prof Petrovsky on COVID-19 vaccine challenges
​​50:50 Q&A
--
*
Visit & Subscribe/Follow Alternative Narrative on:
Website >> https://alternativenarrative.net
Rumble Channel >> https://rumble.com/c/c-1073344
Twitter >> https://twitter.com/altnarr
Facebook >> https://fb.com/alternativenarrative2021
Thank you for visiting.